A very warm welcome to new portfolio company Phlox Therapeutics, a private biotechnology company specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies. Below the press relaese; • Phlox Therapeutics raises additional seed funding to develop RNA therapies for genetic laminopathies • Funds will advance the company’s lead program into preclinical

Bringing new innovations to the market; that is the challenge that we, together with researchers from Utrecht University and UMC Utrecht, face every day at Utrecht Holdings. The goal of our team of 15 expert and enthusiastic employees, is to maximize the impact of academic research on people, society and

Utrecht, The Netherlands Moveshelf is a private digital health company which supplies a novel information system for movement and musculoskeletal disorders. With Moveshelf’s certified Software-as-a-Service, healthcare organizations unlock use of mobility measurements in clinical settings, store data from cameras and wearables in one secure place and allow their medical teams

Our portfolio company Targed Biopharmaceuticals raised Series A financing of € 39 million to develop improved treatments for thrombotic diseases. The financing was co-led by Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures, and joined by existing investors First, Curie Capital and UHSF.   Congratulations to